Figure 2

Mammary tumor onset in MTB-IGFIR, MTB-IGFIR/Akt1 ^-/- and MTB-IGFIR/Akt2 ^-/- mice. The graph shows mammary tumor onset in MTB-IGFIR/Akt1^-/- mice (red line; n=6), MTB-IGFIR/Akt2^-/- mice (green line; n=6) and MTB-IGFIR mice (black line; n=11). The same group of MTB-IGFIR mice were used for both comparisons.